157 related articles for article (PubMed ID: 36809492)
1. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with being diagnosed with high severity of breast cancer: a population-based study in Queensland, Australia.
Kou K; Cameron J; Aitken JF; Youl P; Turrell G; Chambers S; Dunn J; Pyke C; Baade PD
Breast Cancer Res Treat; 2020 Dec; 184(3):937-950. PubMed ID: 32926317
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.
Youl PH; Aitken JF; Turrell G; Chambers SK; Dunn J; Pyke C; Baade PD
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27869758
[TBL] [Abstract][Full Text] [Related]
4. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
7. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
9. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
10. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
[TBL] [Abstract][Full Text] [Related]
11. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
12. Why do large breast cancers still present in a population offered screening?
Kricker A; Newman B; Gertig DM; Goumas C; Armes J; Armstrong BK
Int J Cancer; 2008 Dec; 123(12):2907-14. PubMed ID: 18770865
[TBL] [Abstract][Full Text] [Related]
13. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
[TBL] [Abstract][Full Text] [Related]
14. Molecular comparison of interval and screen-detected breast cancers.
Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
16. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
17. Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.
Yuan Y; Li M; Yang J; Elliot T; Dabbs K; Dickinson JA; Fisher S; Winget M
BMC Health Serv Res; 2016 Feb; 16():65. PubMed ID: 26892589
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
Henderson LM; Miglioretti DL; Kerlikowske K; Wernli KJ; Sprague BL; Lehman CD
AJR Am J Roentgenol; 2015 Sep; 205(3):676-84. PubMed ID: 26295657
[TBL] [Abstract][Full Text] [Related]
20. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]